valaciclovir teva 500 mg film-coated tablets
teva pharma b.v. - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir
zelitrex valaciclovir 500mg (as hydrochloride) tablet bottle
arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with zelitrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
shilova valaciclovir (as hydrochloride) 500mg tablet blister pack
pharmacor pty ltd - valaciclovir hydrochloride -
valaciclovir 500mg tablets
waymade healthcare plc - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
phoenix healthcare distribution ltd - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
pfizer ltd - valaciclovir hydrochloride - oral tablet - 500mg
valtrex valaciclovir 1000mg (as hydrochloride) tablet bottle
arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 1112 mg (equivalent: valaciclovir, qty 1000 mg) - tablet, film coated - excipient ingredients: carnauba wax; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; povidone; magnesium stearate; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
valtrex valaciclovir 250mg tablet blister pack
arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 278 mg (equivalent: valaciclovir, qty 250 mg) - tablet, film coated - excipient ingredients: povidone; macrogol 400; titanium dioxide; crospovidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; hypromellose; microcrystalline cellulose - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
axcel valacyclovir-500 tablet
kotra pharma (m) sdn. bhd. - valaciclovir hydrochloride dihydrate -
valtrex tablets film-coated
glaxosmithkline pharmaceuticals sa - valaciclovir (valaciclovir hydrochloride) - tablets film-coated - 500mg